The Arizona Brain and Heart Symposium
Course Goal
A collaboration of Barrow Neurological Institute and Arizona Heart Rhythm Center, the 2023 Brain-Heart Symposium aims to give an overview of the current state of the art scientific knowledge in neurocardiology. The meeting will consist of a hybrid format, with live guests and speakers, as well as a web-based format for attendees and speakers who will join the meeting virtually. Reuniting speakers specialized in neurology, interventional cardiology and electrophysiology, and cardiac surgery, morning and afternoon sessions will consist of plenary lectures and debates, as well as live interventional cardiology sessions.
Course Learning Objectives
- Define the common conditions of brain-heart related disorders such as stroke, atrial fibrillation, syncope and autonomic disorders
- Review the updated recommendations on the diagnostic workup of those conditions
- Discuss the medical management of stroke prevention, cardiac arrhythmias and syncope
- Explain the therapeutic options in the interventional treatment of atrial fibrillation, stroke prevention, syncope, as well as neurosurgical approaches for other vascular diseases of the brain
Registration Information
| Attendee Type | price |
|---|---|
| In-person Admission with CME Credits | $100.00 |
| Virtual Admission with CME Credits | $90.00 |
| In-person Admission (No CME) | Free |
| Virtual General Admission (No CME) | Free |
| Nurse Admission with CNE Credits | Free |
| Students | Free |
Refund and cancellation policy: Barrow reserves the right to cancel or change the program for due causes. Cancellation of this program by Barrow or by the participant before October 10th will result in a full refund of tuition.
CME Information and Disclosures
- CME/CEU pending
In-Person and Virtual
Friday, October 20-21, 2023
Date, Time, and Location
In Person and Virtual
Friday & Saturday, October 20-21, 2023
Goldman Auditorium
Barrow Neurological Institute
2910 North 3rd Ave
Phoenix, Arizona 85013
Target Audience
The program has been designed to meet the educational goals of cardiologists
and neurologists, including residents and fellows training both specialties, as well as internists, physicians, nurses, and other health care workers involved in the evaluation and treatment of patients with neurologic and cardiac disorders.
Speaker Information
Keynote Speakers
- Walter Koroshetz, MD – Director, NINDS (Friday)
- Kalyanam Shivkumar, MD, PhD – Director, UCLA Cardiac Arrhythmia Center (Friday)
- Michael T. Lawton, MD – President and CEO; Robert F. Spetzler Endowed Chair in Neurosciences; Professor and Chair of Neurosurgery, Barrow Neurological Institute (Friday)
- M. Edip Gurol, MD, MSc – Vascular Neurologist, Fireman Vascular Center, Massachusetts General Hospital (Saturday)
- Lee Schwamm, MD – C. Miller Fisher Chair in Vascular Neurology (Saturday)
All times refer to Arizona time (Pacific Daylight Time).
| SPeaker | Topic & Time |
|---|---|
| Day 1 – Friday, October 20 – Registration, Breakfast and Vendor Exhibit | 9:30 AM |
| David Wang, DO Vijendra Swarup, MD, FACC, FHRS Robert Lemery, MD | Welcome and Introductions to Brain-Heart (9:55 AM) |
| Moderators: Arjum Gururaj, MD; Vivek Reddy, MD; Robert Lemery, MD | Session I: Interventional Electrophysiology – Ablation of Atrial Fibrillation (Live and Pre-Recorded Cases) |
| Vijendra Swarup, MD Sudarone Thihalolipavan, MD | EP Lab Introduction of Clinical Team and Patient Summaries (10:00 AM) |
| Robert Lemery, MD | AF Ablation 1998-2023: The first 25 years (10:10 AM) |
| Vijendra Swarup, MD Sudarone Thihalolipavan, MD | The Interventional EP Lab: Progress of AF Ablation Procedures (10:20 AM) |
| Vivek Reddy, MD | AF Ablation: Current Status and Expectations (10:30 AM) |
| Vivek Reddy, MD | AF Ablation: Emergent New Modalities & Therapies (10:40 AM) |
| All Moderators and Panelists | Q&A (10:50 AM) |
| Vijendra Swarup, MD Sudarone Thihalolipavan, MD | The Interventional EP Lab: Progress of AF Ablation Procedures (11:00 AM) |
| Dhanujaya R. Lakkireddy, MD | Clinical Cases No. 1. My Patient Who Required Multiple (many) AF Ablation Procedures (11:10 AM) |
| Arjum Gururaj, MD Vivek Reddy, MD Dhanujaya R. Lakkireddy, MD Sudarone Thihalolipavan, MD Vijendra Swarup, MD Robert Lemery, MD | Panel Discussion and Q&A (11: 20 AM) |
| Lunch | 11:40 AM |
| Dominika Zoltowska, MD | Latest Guidelines for Aggressive Lipid Reduction for Secondary Prevention of MI and CVA (12:00 PM) |
| Richard Foster, MS, RVS, RVT, RDMS | The Magic of Transcranial Doppler (12:15 PM) |
| Stacy Parlette, RN | Factor XI Inhibition: Ongoing Clinical trials (12:30 PM) |
| Break | 12:45 PM |
| Moderator: David Wang, DO; Vijay Swarup, MD; Robert Lemery, MD | Session II: Keynote Presentations |
| Keynote Speaker: Walter Koroshetz, MD Director, National Institute of Neurological Disorders and Stroke | Brain Health Initiatives of United States (1:00 PM) |
| Keynote Speaker: Kalyanam Shivkumar, MD Medical Director, UCLA Cardiac Arrhythmia Center | Cardiac Neuromodulation Initiatives of United States (1:35 PM) |
| Keynote Speaker: Michael T. Lawton, MD President and CEO, Barrow Neurological Institute | Surgery for Cavernous Malformations (2:10 PM) |
| Moderators: Pallavi Bellamkonda, MD; Dhanujaya R. Lakkireddy, MD; Vijendra Swarup, MD; Robert Roberts, MD; Kevin Brady, MD | Session III: Interventional Cardiology – The Prevention of Stroke (Live and Pre-Recorded Cases) |
| Bimal Padaliya, MD | Clinical Trial Data of PFO Closure for Cryptogenic Stroke (2:40 PM) |
| Hursh Naik, MD | Septal Occlusion and Mechanical Sealing of the Left Atrial Appendage (2:50 PM) |
| Saibal Kar, MD | Left Atrial Appendage Closure: Endovascular Snaring of the LAA (3:00 PM) |
| Vijendra Swarup, MD | Purposely Creating an Interatrial Shunt to Treat CHF (3:10 PM) |
| Kevin Brady, MD | The Management of Anticoagulation in the LVAD Patient (3:20 PM) |
| Hursh Naik, MD Saibal Kar, MD Dhanujaya R. Lakkireddy, MD Bimal Padaliya, MD Vijendra Swarup, MD Kevin Brady, MD | Panel Discussion and Q&A (3:30 PM) |
| Break | 3:40 PM |
| Moderator: Sunny Po, MD; Robert Lemery, MD; David Wang, DO | Session IV: Neuromodulation of Cardiac Arrhythmias |
| Vivek Reddy, MD | Renal Denervation in Patients with Hypertension and Atrial Fibrillation (4:00 PM) |
| Dhanujaya R. Lakkireddy, MD | Surgical Treatment of Inappropriate Sinus Tachycardia (4:10 PM) |
| Kalyanam Shivkumar, MD | Thorascopic Cardiac Sympathetic Denervation for Patients with VT Storm (4:20 PM) |
| Sunny Po, MD | Cardiac Ganglia Ablation for Patients with Cardio-Inhibitory Syncope (4:30 PM) |
| Sunny Po, MD | Clinical Cases No. 3. My Patient with Recurrent Cardio-Inhibitory (4:40 PM) |
| Vivek Reddy, MD Kalyanam Shivkumar, MD Sunny Po, MD David Wang, DO Robert Lemery, MD Dhanujaya R Lakkireddy, MD | Panel Discussion and Q&A (4:50 PM) |
| Adjourn | 5:10 PM |
| Cocktails & Dinner Marley Lobby/Sonntag Pavilion | 5:30 PM |
| Day 2 – Saturday, October 21 – Breakfast and Vendor Exhibit | 8:30 AM |
| David Wang, DO Vijendra Swarup, MD Robert Lemery, MD | Welcome & Introduction to Brain-Heart (8:55 AM) |
| Moderators: David Wang, DO; Brain Olshansky, MD; Robert Lemery, MD | Session V: Syncope |
| Justin Hoskin, MD | Autonomic Imbalance and Dysautonomias: Primary Neurologic Disorders Affecting Day-to-Day Regulation of Blood Pressure (9:00 AM) |
| Sudarone Thihalolipavan, MD | Cardiac Syncope: Primary Cardiac Causes of Loss of Conscience: Bradycardia, Tachycardia and Other (9:10 AM) |
| Brain Olshansky, MD | The Role of Tilt-Testing in the Evaluation of Patients with Cardio-Inhibitory or Vasodepressor Syncope (9:20 AM) |
| Brain Olshansky, MD | Driving and Cycling Restrictions in Patients with Syncope (9:30 AM) |
| Sudarone Thihalolipavan, MD | Clinical Cases No. 4. Syncope and Sports (9:40 AM) |
| Justin Hoskin, MD Sudarone Thihalolipavan, MD Brain Olshansky, MD David Wang, DO Vijendra Swarup, MD Robert Lemery, MD | Panel Discussion and Q&A (9:50 AM) |
| Break | 10:10 AM |
| Moderators: Vijendra Swarup, MD; Edip Gurol, MD; David Wang, DO | Session VI: Pharmacology and Antithrombotic Therapies |
| Tyler Haller, Pharm D | Pharmacology of Antithrombotic Drugs (10:30 PM) |
| Daniel Gonzalez, MD | Antithrombotics for Stroke Prevention: What are the current guidelines? (10:40 AM) |
| Supreet Kaur, MD | Embolic Stroke of Unknown Source: How do we manage? (10:50 AM) |
| Edip Gurol, MD | Individualized Stroke Prevention in Atrial Fibrillation: The Crossroads of Neurology and Cardiology (11:00 AM) |
| Edip Gurol, MD Daniel Gonzalez, MD Supreet Kaur, MD David Wang, DO Vijendra Swaru, MD Tyler Haller, Pharm D | Panel Discussion and Q&A (11: 20 AM) |
| Lunch | 11:40 AM |
| Patrycja Kuszka, PA-C | Fitbit, Apple Watch, and Alive Cor-Kardia: Digital Recording of Atrial Fibrillation (12:00 PM) |
| Jacob Hantla, CRNA | The Administration of Conscious Sedation and General Anesthesia (12:15 PM) |
| Shelby Wirtanen, RN | Mobile Stroke Units 2023 (12:30 PM) |
| Break | 12:45 PM |
| Moderators: Edip Gurol, MD; Andrew Ducruet, MD; David Wang, DO | Session VII: Interventional Neurology and Neurosurgery |
| Kerry Knievel, DO | Headache: When is it serious? (1:00 PM) |
| Andrew Ducruet, MD | Subarachnoid Hemorrhage: Emerging Neurosurgical Interventions (1:10 PM) |
| Andrew Ducruet, MD | The Neuroradiologist: Opening and Embolizing Brain Vessels (1:20 PM) |
| David Wang, DO | Intracerebral Hemorrhage: Anything we can do? (1:30 PM) |
| Francisco Ponce, MD | Deep Brain Stimulation (1:40 PM) |
| David Wang DO Edip Gurol, MD Kerry Knievel, DO Andrew Ducruet, MD Francisco Ponce MD | Panel Discussion and Q&A (1:50 PM) |
| Break | 2:10 PM |
| Moderators: David Wang, DO; Vijay Swarup, MD; Robert Lemery, MD | Session VIII: Brain-Heart Wonders |
| Lee Schwamm, MD | Artificial Intelligence: Ready, Set, Go (2:30 PM) |
| Adjourn | 3:00 PM |
Course Directors
Vijendra Swarup, MD, FACC, FHRS
Director
Arizona Heart Rhythm Center
Arizona Heart Rhythm Center
Robert Lemery, MD, FACC, FHRS
Electrophysiologist
Arizona Heart Rhythm Center
Arizona Heart Rhythm Center
Commercial Promotion
Exhibitors and Sponsors
Platinum
- Siemens
Gold
- Boston-Scientific
Silver
- BioSense
- AstraZeneca
- Impulse Dynamics
Bronze
- Genentech
- Bristol Myers-Squibb
- Stryker
- Abbott- CRM
- Boehringer Ingelheim
- Chiesi USA
- Amgen
- Atricure
- Medtronic
- Amylyx
Disclosure Information
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any ineligible company held in the last 24 months. Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.